While prostate cancer lags behind other solid tumors in the evaluation of adjuvant systemic therapy, the role for docetaxel-based chemotherapy and ADT in this setting should soon become better ...

like prostate cancer. Specific characteristics of the cancer can help determine whether or not to use adjuvant therapy. For ...

Patients with pT3N0M0 disease after radical prostatectomy for localized prostate cancer are at risk ... among patients who received adjuvant radiation therapy than in those who received ...

White button mushrooms promoted antitumor activity among men with prostate cancer, according to results of an ongoing ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on the rise. In Thailand, it is the 4th most common cancer among men (1), ...

AstraZeneca had a disappointing trial readout with its AKT inhibitor Truqap in breast cancer in June ... at least one prior endocrine treatment or earlier adjuvant therapy. Its approved label ...

A randomised, multicentre, open label, phase III study of adjuvant lapatinib ... radiotherapy vs SBRT for early stage organ-confined prostate cancer. Photo-dynamic versus white light-guided treatment ...

Adjuvant androgen-deprivation therapy (ADT) has similarly shown ... proven for docetaxel in metastatic castration-resistant prostate cancer. Several large-scale RCTs investigating neoadjuvant ...